Moreover, our most prevalent CH mutations, including DNMT3A, TET2, and PPM1D, were marginally affected by smoking, and this trend has been consistently observed in both healthy populations and NSCLC patients (Bolton et al., 2020; Levin et al., 2022). Here, TET2 is linked to non-small cell lung carcinoma.